Weekly Roundup -
December 10, 2025
Smart. Strategic. Essential.
Unmatched Healthcare Insights from HMA,
Leavitt Partners & Wakely.
Featured:
Updated Analysis Compares Consumer Out-of-Pocket Spending of ACA Marketplace Enrollees to other Major Payers Using Claims Data
READ BRIEFWebinar Replay – Redefining Revenue: Building Financial Resilience in an Era of Policy and Payment Change
ACCESS WEBINARTrending: In Focus
CMS Innovation Center’s ACCESS Model: What Medicare Organizations Need to Know
On December 1, 2025, the Centers for Medicare & MedicaidServices(CMS)Innovation Center announced its latest model—(Advancing Chronic Care with Effective, Scalable Solutions).Anational, voluntary 10-year modeldesigned totest outcomes-focused payment fortechnology-enabled careusedin managing chronic conditions common among Original Medicare (fee-for-service) beneficiaries, ACCESS addresses the long-standing gap between Medicare’s payment system and technology’s capacity to improve healthcare delivery.
The digital health technology and provider communities have expressed considerable interest in ACCESS. The US Department of Health and Human Services (HHS) and CMS highlighted the model at theDecember4, 2025,Modernizing America’s Care for the Betterevent(recordinghere), noting over 250 organizations have already expressed interest in the model.Nonetheless,many detailsneedclarification beforetheprogram launches.
(HMA)has reviewed the ACCESS model andis engaging withthoseagenciesand organizationsworking ondesign and implementation.In this article, weshareearly insights and considerations for Medicare organizationsand technology manufacturersinterested inparticipating, as well as potential implications for the broader market.
Model Overview
ACCESSaligns with the administration’s strategic priorities forthe Innovation Center,including:
- Incentivize greater use oftechnologyinchronicdisease prevention and management
- Increase access totech-enabled careby overcomingpaymentbarriers, while ensuring care is clinician-guided, coordinated, and accountable
- Expandclinicians’ability to offer innovative care throughastraightforward payment pathway
- Promote competition by publishing risk-adjusted performance results
- Reduce overall Medicare costs
Core Requirements for ACCESS Participants
Participants in the model(ACCESS care organizations)must be Medicare PartBparticipatingproviders or suppliers,exclusive ofdurable medicalequipment, prosthetics, orthotics, and laboratory suppliers. Notably, these organizations mustdesignatea Medicare-enrolledmedicaldirectorto oversee care quality and compliance. These organizationswillcollaborate with primary care providersand other referring clinicians to offer tech-enabled servicesthatcomplement traditional care, including:
- Telehealth software
- Wearable devices for continuous monitoring (e.g., sleep, heart rate, movement, glucose, etc.)
- Appstotrack and coach lifestyle changes
Care may bedeliveredin person, virtually, asynchronously, or through otherclinicallyappropriatetech-enabledmethods.
While CMS has yettorelease full details on covered digital health solutions, ACCESS care organizationsareexpected to offer integrated, technology-supported care,which may include:
- Clinician consultations
- Lifestyle and behavioral support (e.g., nutrition, exercise, smoking cessation)
- Therapy and counseling
- Patient education
- Care coordination
- Medication management
- Ordering and interpreting diagnostic tests and imaging
- Use ormonitoringof Food and Drug Administration(FDA)-authorized devices
ACCESS isintendedto be a supplemental approach to traditional care. Primary care physicians and specialists will be able to refer patients to ACCESS organizations and will receive regular electronic updates on patient progress.
NewOptions forBeneficiaries
Unlike most otherInnovation Centermodels, beneficiaries will be able to voluntarily sign up directlywith anACCESS organizationorreceive areferral fromaphysician. CMS willmaintaina public directory of ACCESS participants,including the conditions they treat and their risk-adjusted outcomes, to helpproviders and beneficiariesmake informed choices based on their needs.
Chronic Condition FocusedClinical Tracks
ACCESS willlaunch withfour clinical tracks, groupingrelated conditionswithsimilarcare approaches.AlthoughCMS may addadditionaltracks and conditions in the future, the first four tracks address common chronic conditions among Medicare beneficiaries (affectingovertwo-thirds of Medicarebeneficiaries).
- Early Cardio-Kidney-Metabolic (eCKM):Hypertension, dyslipidemia, obesity, prediabetes
Outcome measures:Controlofor improvement inblood pressure(BP), lipids, weight, HbA1c - Cardio-Kidney-Metabolic (CKM):Diabetes,chronic kidney disease(CKD),atheroscleroticcardiovasculardisease(ASCVD)
- Outcome measures:Control or improvement in BP, lipids, weight, HbA1c; CKD/diabetes require eGFR(estimatedglomerularfiltrationrate)and UACR(urinealbumin-to-creatinineratio)data submission
- Musculoskeletal (MSK):Chronic pain
Outcome measures:Improvement in pain intensity, interference, function (via validatedpatient-reportedoutcomemeasures[PROMs]) - Behavioral Health:Depression and/or anxiety
Outcome measures:Improvement in symptoms (Patient Health Questionnaire-9[PHQ-9],GeneralizedAnxietyDisorder-7[GAD-7]);submission ofWorld Health Organization Disability Assessment Schedule 2.0(WHODAS 2.0)for overall function
Participant organizations must manage all qualifying conditions within their chosen track.
Payments
CMSwill release more details in the forthcomingrequest forapplications (RFA).The model will use two payment approaches:
- Outcomes-Aligned Payments (OAPs): Paid to ACCESS organizationsthatachievedesired clinical outcomes, support technology-enabled interventions,and net savings for Medicare. OAPs are expected to berecurring(likelymonthly) payments
- Co-managementPayments:Referring clinicians will receive approximately $30 per service, plus a one-time $10 bonus, for onboarding beneficiaries
To promote access in underserved areas, CMS will apply a fixed adjustment to OAPs for rural patients in qualifying tracks.
FDA’s ComplementaryTEMPO Pilot
TheFDA’s(TEMPO)pilotwill work collaboratively with the ACCESS model.Manufacturersof digital health devicesthat haveyetto receiveFDAauthorizationcan apply to TEMPO for enforcement discretion, allowing their devices to be usedbyACCESS participants for covered care.The FDA is seeking statements of interest for participation in the TEMPO pilot beginning in January 2026.The agencyplans to select up to10manufacturers in each of four specific clinical use areas toparticipatein the pilot.
Next Steps
Interested applicantsshould begin exploringparticipationas a Medicare Part B-enrolledprovideriftheyhave yet to enroll.Other key considerations for Medicare organizationsinclude:
- a nonbinding letter of interest tothe Innovation Center
- Evaluate readiness to deliver technology-enabled, outcomes-focused care
- Assess capacity to manage qualifying conditions across clinical tracks
- Plan for data collection, reporting, and performance measurement
- Consider partnerships with technology vendors and referring clinicians
- Monitor regulatory developments and paymentmethodologyupdates
How HMA Can Help
HMAcan help organizationsnavigate the application process, develop implementation strategies, and position your organization for success in the evolving Medicare landscape.If your organization is consideringparticipation in ACCESS or wants to understand how this model couldaffectyour market,contactour experts,Amy Bassanoand.
Preparing for Medicaid Community Engagement Requirements—Key Steps and Opportunities for States and Plans
OnDecember8, 2025, the Centers for Medicare & Medicaid Services (CMS) issuedanticipatedon Medicaid community engagement requirements, asestablishedinthe 2025 budget reconciliationlegislation (P.L. 119-21,referred to as OBBBA).This guidance arrives at a pivotal moment, as states begin budget planning and legislative sessions.
(HMA) reviewed the guidance in the context of other policy and financing shifts that are affecting the Medicaid program. This article highlights key takeaways, addresses considerations for implementation, and issues for policymakers and healthcare organizations to track.
Brief Background
Generallyspeaking,Section71119ofOBBBArequires states to implement community engagement requirements as a condition of Medicaid eligibility for individuals in the expansion populationages19−64 who areneitherpregnantnorenrolled in Medicare or any other mandatory Medicaid group.The guidance explainsthe statutory requirements related tohowstates verify community engagement, notify applicants and beneficiaries, ensure compliance with federal standards as the January 2027 deadline approaches, and other core components of the policy.
Starting January 1, 2027, states must require certain Medicaid expansion applicants to demonstrate community engagement for at least one month and may require up to three consecutive months immediately prior to the month of application.If compliance or exemption statusisunverifiableat the time of application, states must provide notice and an opportunity to respond. Theseenrolleeswillmaintaincoverage during the response period. States are also expected toestablishclear documentation standards and proactive communication processes for applicants and enrollees.
Three Key Takeawaysfrom the Initial Guidance
1. Organizations must understand the key dates leading up to January 1, 2027
Limitednewfundingandtight timelines makeJanuary 1,2027,a critical deadlineforimplementation.Medicaid organizations need toconsider, however,thefullsequence of events leadingupto that date,includingproviding required advance notification to individuals aboutthechangesand their eligibility status.Documentation and progress tracking are essential, both for compliance and todemonstratethatCMSdeadlines are being met.
Althoughthe guidance outlines notice and response requirements, it leaves open critical questions about how states will prevent procedural disenrollments, manage increased appeals volume, and mitigate due process legal risk if eligibility and verification systems fail at scale.
2. Medicaid managed care organizations (MCOs) have a limited role in decision-making but are key to engagement
Medicaidmanaged careorganizationsare prohibited from makingthedetermination that an individualhasmetthe community engagement requirement; however,theyhaveanopportunity tosupport individuals in a range of ways.Recent changes underOBBBAgiveplans clearer authority to conduct proactive outreach on eligibility and renewal requirements, which strengthens their ability to help members navigate deadlines, reporting expectations, and documentation needs.Thiscapacitywill be important because a lack of predictability in enrollment and churn can meaningfullyaffectthe risk profile of plans and, as a result,increase volatility in provider negotiations.
Plans, providers, community organizations, andstateand localagenciescan collaborate todevelop effectiveengagement strategies, alignedmessaging, andongoing touch points.Helping members understand what isrequired—and when—and connecting them with resources totake actionwill beessential for successful implementation.
3. States and partner organizations need a global view of IT changes and functionality
CMS emphasizes that theeligibility determinations for thecommunity engagementrequirements should function seamlessly with new and existing system functionality.Meeting this expectation requires states to haveadeepunderstanding ofwhether and how policies can be operationalized in their systems without addingadministrativeburden for individuals andothers that engage with the systems.
Meetingfederal expectationsmay beparticularly challengingforstateswithcounty-based Medicaid systems, as implementingthese requirementsacrossmultiplejurisdictionsmaynecessitatea longer transition period.TheOBBBAincludes$200 million in totalgrant funding forimplementation activities in2026, andstates can apply forenhanced federalITfundingat the 90/10or 75/25ratesfor certain costs and activities.Federal resources areotherwiselimited,soit iscritical that states and partner organizationsestablishawell-defined strategy to maximize available fundingtosupport thesystemchangesrequiredto implementOBBBAeligibility requirements.
What to Watch
The guidance arrives as many governors begin releasing their budget proposals andplanning forupcoming legislative sessions. Although the guidance provides clear information on the overarching parameters and a preliminaryroadmap, certain critical details are forthcoming.State budgetsshould reflect the requirementsandanticipatethe need for rapid system and process development.
CMS willissue an interim final rule by June 1, 2026,and states must implement thecommunity engagementrequirementno later thanJanuary 1, 2027.States mustcomply withthese requirementsandact quickly to develop, pay for, and implement new systems, policies, and processes—ideallybeforethe latter half of2026.
CMSis developingadditionalguidance in several areas, including:
- Use of reliable data sourcesandhow tosatisfythe definition of engagement
- Implementation of the requirement to conduct renewals every six months for certain individuals
- Specific documentation requirements for community engagement
- Potential role that managed care plans can playunrelated todeterminingbeneficiary compliance
States and Medicaid organizations should closelymonitorthese developments and be prepared to adjust their strategies asnew informationbecomes available.
Connect with Us
HMA’s experts are trusted problemsolvers, partnering with states to navigate the complexities of community engagement planning,even as requirements and details continue to evolve. Drawing on deep state and federal experience, as well as lessons learned frompreviouslarge-scale eligibility reforms, our team helpsMedicaid-focused organizationsquickly designand implement practical, context-specific strategies that align with OBBBA requirements. Whetherit’sstrategy development, system design, or crafting effectivemessages, HMA brings a flexible, solutions-oriented approach to maximize continuity of coverage and meet each client’s unique needs.
Contactour featured experts,Loren Anthes,Andrea Maresca,Juan Montanez,andTonya Mooreto discuss how we can support your team in navigating these changes and building effective engagement strategies.
Federal Policy News
Fueled By Weekly Health Intelligence
Federal Health Agencies Align Under New HHS AI Strategy
On December 4, HHS released its first department-wide , outlining a coordinated plan to deploy artificial intelligence (AI) across internal operations, public health activities, and federally supported research. The strategy, developed by Acting Chief AI Officer Clark Minor and aligned with recent government-wide AI directives, establishes five pillars:
- Governance and risk management
- Infrastructure and platform development
- Workforce support and burden reduction
- Research reproducibility and scientific rigor, and
- Modernization of care and public health delivery
The announcement emphasizes a “OneHHS” framework, bringing together agencies across the department, including CDC, CMS, FDA, and NIH, to build shared AI infrastructure, enhance cybersecurity, and streamline workflows. While focused primarily on internal federal operations, the strategy notes that future phases will involve collaboration with private-sector stakeholders. The announcement follows President Trump’s , “Launching theGenesisMission,” a new federal initiative aimed at using AI to accelerate scientific discovery and modernize the nation’s research infrastructure, as well as several other ongoing efforts within HHS to leverage AI. These include the use of internal AI tools to improve department operations and processes, such as FDA’s “Elsa” internal tool, or funding opportunities in which agencies have sought solicit participation from private sector organizations in various grant or pilot programs related to the development and use of AI tools.
New ARPA-H CATALYST Investments Aim to Transform Preclinical Testing
On December 4, ARPA-H announced awardees for its new Computational ADME-Tox and Physiology Analysis for Safer Therapeutics () program, a multi-year initiative designed to modernize drug development using AI-driven, human-based safety models. The goal of the program is to significantly reduce reliance on traditional animal testing, shorten development timelines, lower costs, and improve the ability to predict safety and efficacy before human trials. CATALYST will fund work to build in silico models capable of simulating investigational drug safety and toxicity, especially across patient populations often underrepresented in clinical research, such as children and pregnant women. The total program award amount is up to $125 million over 4.5 years, and teams selected span academic institutions, biotech companies, and research labs, including:
- Draper Laboratory, developing a multi-layer “human data stack” to model patient-specific responses
- Deep Origin, building an FDA-qualifiable platform for AI-enabled ADME-Tox prediction aimed at reducing and replacing animal models
- Inductive Bio, integrating AI with organ-specific physiological models to improve early detection of liver and heart toxicities
- The Jackson Laboratory, generating digital cardiovascular models to better detect non-arrhythmic cardiotoxicity across diverse genetic profiles
- Black Mesa Technology, developing a regulatory-grade, secure AI framework for CATALYST tools
- Cedars-Sinai, creating cell-based cardio- and neurotoxicity models informed by real-world patient variation
- Peptilogics, focusing on peptide-drug safety, including off-target interactions and modifications
- University of North Carolina, building antibody-drug organ-on-chip models and predictive platforms, including for pregnant individuals
CATALYST Program Manager Dr. Andy Kilianski noted, “CATALYST’s data and computational tools will make shorter development timelines, less expensive therapies, and better patient safety a reality.”
FTC Warns Major For-Profit Health Systems on Noncompete Restrictions
The Federal Trade Commission (FTC) warning letters to 19 major for-profit health systems and staffing firms, including HCA Healthcare, Tenet Healthcare, and Universal Health Services, urging them to ensure employment contracts do not include anticompetitive noncompete provisions that could limit workers’ mobility and patient access to care. The outreach disclosed following a public records request, signals continued federal scrutiny of potentially illegal noncompete agreements in healthcare after the FTC’s broader nationwide ban effort stalled last year. The letters did not allege specific violations but put companies on notice to review their practices.
Ready to talk about your organization's challenges?
Schedule a ConsultationState Policy News
Idaho
Idaho Judge Rules State Can Cut Mental Health Medicaid Services. The Idaho Capital Sunon December 3, 2025, that Idaho Fourth District Judge Derrick O’Neill has rejected a request to pause Medicaid behavioral health contractor Magellan of Idaho from cutting certain mental health services. Beginning December 1, 2025, Magellan cut specialized mobile teams for patients with severe mental illness. O’Neill denied the request on grounds that there was not enough information to suggest that the lawsuit, brought forth by mental health clinics in the state, would succeed on legal merit.
Louisiana
Louisiana Terminates Medicaid MCO Contract. The Louisiana Illuminatoron December 9, 2025, that the Louisiana Department of Health (LDH) will be ending its Medicaid contract with managed care organization (MCO) UnitedHealthcare of Louisiana on January 1, 2026. The state reversed its cancellation of CVS Health/Aetna Better Health’s contract after LDH held discussions with the plan. Lawmakers had initially voted to renew all six MCO contracts through 2026, but state officials cited litigation surrounding pharmacy benefit managers affiliated with Aetna and United. United’s 330,700 Medicaid members will need to find care with one of the other MCOs in the state: Aetna, AmeriHealth Caritas, Elevance Health, Humana, and Centene/Louisiana Healthcare Connections.
Minnesota
Minnesota Petitions to Take Control of UCare. Modern Healthcareon December 9, 2025, that the Minnesota Department of Health has petitioned to a state judge to allow the department to take control of UCare, which would enter the company into rehabilitation while it winds down operations, and also liquidate the business. UCare is scheduled to shut down in 2026 after facing major financial losses and being acquired by Medica. The rehabilitation would not affect Medica’s acquisition.
New York
New York Awards $46 Million to Expand Supportive Housing Statewide. Crain’s New York Businesson December 10, 2025, that New York Governor Kathy Hochul announced $46 million in new awards through the Empire State Supportive Housing Initiative to expand housing for veterans, people experiencing homelessness, and individuals with mental illnesses or disabilities. The state issued 200 grants to support more than 8,000 units, the largest round since the program began in 2016, following a 53 percent budget increase last year that raised annual per-unit funding to $34,000. In this cycle, 54 grants went to NYC organizations, 21 to Long Island, and 25 to the mid-Hudson region, with some providers receiving multiple awards.
New Hampshire, Pennsylvania
New Hampshire, Pennsylvania to End Medicaid Coverage of GLP-1 Drugs for Weight Loss. and will end Medicaid coverage of GLP-1 medications used solely for weight loss beginning January 1, citing high costs.Coverage in both states will continue for enrollees who have diabetes and certain other conditions.
Private Market News
Fueled By
Wellvana, Mercy Partner to Expand Value-Based Care
Wellvana and Mercy have a 20-year affiliation to expand value-based care participation among Mercy’s non-employed primary care providers and advanced practice clinicians. The partnership will give independent practices access to Wellvana’s EHR-integrated tools, care coordination teams, and population health capabilities, with financial incentives tied to improved outcomes across Medicare, Medicare Advantage, and commercial plans. The organizations expect their clinically integrated network to become one of the largest in the country.
ACA Sign-Ups Ahead of Last Year as Subsidy Expiration Looms
Early federal data 2026 Affordable Care Act enrollment is modestly ahead of last year at this point in the sign-up period, with nearly 5.8 million selections through the first 29 day; however, analysts caution it is too soon to determine the ultimate impact of enhanced premium subsidies expiring at the end of 2025, which could drive higher consumer costs and potential disenrollment later in the cycle. Many individuals may still be waiting to see whether Congress acts to extend the subsidies before making final coverage decisions.
Our Insights
Fueled By Experts Across Our HMA Companies
ACA Marketplaces at a Crossroads: New Analysis Compares Out-of-Pocket by Major Payers
As we approach the end of 2025, the Affordable Care Act (ACA) Marketplaces face a pivotal moment. Enhanced Advance Premium Tax Credits (APTCs), introduced under the American Rescue Plan Act (ARPA) and extended through the Inflation Reduction Act (IRA), have driven enrollment to 24 million individuals now covered through the Marketplaces. Without congressional action, these subsidies expire on December 31, 2025.
HMA and Wakely, an HMA Company, have released updated analysis that compares enrollee out-of-pocket spending of ACA marketplace enrollees to other major payers using claims data. The brief answers key questions about Marketplace enrollees and whether they spend more or less out-of-pocket relative to Medicare, ESI and Medicaid enrollees.
Wakely
WRI ACO – MSSP 2024 Insights
The WRI ACO study reviews the latest PY2024 MSSP financial and quality results for key insights into drivers of success. The Wakely team has studied various ACO characteristics that are aligned with higher savings rates in the program. From, duals mix and quality metric performance to regional adjustments and primary care to specialist provider ratios.
Leavitt Partners
Webinar: The Block Stops Here: Unlocking Access to Health Data
Information blocking continues to hinder timely access to electronic health data for patients, providers, payers, and the federal government. While federal regulations prohibit interference with data exchange, in practice key participants across the health data landscape continue to limit access in ways that constrain care delivery, population health efforts, operational innovation, and more. Because of insufficient enforcement of these regulations, data continue to be delayed or withheld from patients, clinicians, payers, and networks–resulting in medical errors, redundant tests, higher costs, and fragmented care. Now is the time for more robust federal enforcement of information blocking regulations.
Join Leavitt Partners’ Ryan Howells and David Lee and AVIA’s Amberly Diets for a discussion of what challenges exist, solutions under consideration and why data and information liquidity are so critical.
Webinar: Understanding the Policy Landscape of Upstream Drivers of Health
Join HMA and the National Alliance for Impacting the Social Determinants of Health (NASDOH), an alliance managed by Leavitt Partners, an HMA Company, for an in-depth discussion on the evolving policy landscape on the upstream drivers of health, which includes the social, economic, and environmental conditions that influence whether people can achieve and maintain good health. This session will explore the latest federal changes, including changes to Medicaid guidance, payment models, and quality measures, as well as innovative state opportunities. Our experts will highlight how stakeholders can screen for health-related social needs and address upstream drivers to improve health outcomes for all Americans, including the evidence-base for these activities.
Webinar Alert
Understanding the Policy Landscape of Upstream Drivers of Health
RFP Calendar
RFP Calendar
| Date | State/Program | Event | Beneficiaries |
|---|---|---|---|
| Date: DELAYED | State/Program: Texas STAR & CHIP | Event: Implementation | Beneficiaries: 4,600,000 |
| Date: December 2025 - February 2026 | State/Program: Texas STAR Kids | Event: Awards | Beneficiaries: 150,000 |
| Date: January 1, 2026 | State/Program: Wisconsin LTC GSR 2,7 | Event: Implementation | Beneficiaries: 56,000 (all GSR) |
| Date: January 1, 2026 | State/Program: Michigan HIDE SNP | Event: Implementation | Beneficiaries: 35,000 |
| Date: January 1, 2026 | State/Program: Nevada D-SNP | Event: Implementation | Beneficiaries: 88,000 |
| Date: January 1, 2026 | State/Program: Ohio Duals | Event: Implementation | Beneficiaries: 250,000 |
| Date: January 1, 2026 | State/Program: Illinois D-SNP | Event: Implementation | Beneficiaries: 79,000 |
| Date: January 1, 2026 | State/Program: Nevada | Event: Implementation | Beneficiaries: 674,000 |
| Date: January 1, 2026 | State/Program: Massachusetts One Care, Senior Care Options | Event: Implementation | Beneficiaries: 120,000 |
| Date: January 6, 2026 | State/Program: Nevada Children's Specialty | Event: Proposals Due | Beneficiaries: NA |
| Date: January 16, 2026 | State/Program: Wisconsin LTC GSR 3 | Event: Proposals Due | Beneficiaries: 56,000 (all GSR) |
| Date: February 2026 | State/Program: Illinois | Event: Awards | Beneficiaries: 2,400,000 |
| Date: February 19, 2026 | State/Program: Nevada Children's Specialty | Event: Awards | Beneficiaries: NA |
| Date: June 24, 2026 | State/Program: Wisconsin LTC GSR 3 | Event: Awards | Beneficiaries: 56,000 (all GSR) |
| Date: December 2026 - February 2027 | State/Program: Texas STAR Kids | Event: Implementation | Beneficiaries: 150,000 |
| Date: January 1, 2027 | State/Program: Illinois | Event: Implementation | Beneficiaries: 2,400,000 |
| Date: January 1, 2027 | State/Program: Nevada Children's Specialty | Event: Implementation | Beneficiaries: NA |
| Date: January 1, 2027 | State/Program: Wisconsin LTC GSR 3 | Event: Implementation | Beneficiaries: 56,000 (all GSR) |
| Date: January 1, 2028 | State/Program: Wisconsin LTC GSR 4,6 | Event: Implementation | Beneficiaries: 56,000 (all GSR) |
| Date: Fall 2027 | State/Program: Oregon | Event: RFP Release | Beneficiaries: 1,200,000 |
| Date: 2028 | State/Program: North Carolina | Event: RFP Release | Beneficiaries: 2,200,000 |